InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,968.35
(
0.66%
)
US TECH 100
20,491.60
(
1.33%
)
Dow Jones
43,767.19
(
0.09%
)
Brent Oil
75.53
(
0.61%
)
Bitcoin
76,294.06
(
0.87%
)
Post# of 253543
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

daved

Send PM Follow Ignore
Followers 4
Posts 294
Boards Moderated 0
Alias Born 11/13/2006

daved

Re: AlpineBV_Miller post# 45271

Tuesday, 04/17/2007 6:27:46 AM

Tuesday, April 17, 2007 6:27:46 AM

Post# of 253543
Re DNDN BSRdavid summation. Yes.

The lines are clearly drawn for the current stances on DNDN.

To me the heart of the matter is that "substantial evidence" is reaffirmed as the basis for most committees' recommendations. This is good for biotech value in the intermediate term.

Dave
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up